Light‐based volumetric bioprinting enables fabrication of cubic centimeter‐sized living materials with micrometer resolution in minutes. Xolography is a light sheet‐based volumetric printing technology that offers unprecedented volumetric generation rates and print resolutions for hard plastics. However, the limited solubility and reactivity of current dual‐color photoinitiators (DCPIs) in aqueous media have hindered their application for high‐resolution bioprinting of living matter. Here, we present a novel three‐component formulation that drastically improves photoreactivity and thereby enables high‐resolution, rapid, and cytocompatible Xolographic biofabrication of intricately architected yet mechanically robust living materials. To achieve this, various relevant additives are systematically explored, which revealed that diphenyliodonium chloride and N ‐vinylpyrrolidone strongly enhance D‐mediated photoreactivity, as confirmed by dual‐color photo‐rheology. This enables Xolographic bioprinting of gelatin methacryloyl‐based bioresins, producing >1 cm 3 constructs at ≈20 µm positive and 125 µm negative resolution within minutes. Multimaterial printing, molecular patterning, and grayscale‐mediated mechanical patterning are explored to programmably create intricate, biomimetic, and concentration‐controlled architectures. We demonstrate the Bioxolographic printing of various cell types, showing excellent cell viability, compatibility with long‐term culture, and ability for nascent protein deposition. These results position Bioxolography as a transformative platform for rapid, scalable, high‐resolution fabrication of functional living materials with encoded chemical and mechanical properties.
Osteoarthritis (OA) is a multifactorial degenerative joint disease of which the underlying mechanisms are yet to be fully understood. At the molecular level, multiple factors including altered signaling pathways, epigenetics, metabolic imbalance, extracellular matrix degradation, production of matrix metalloproteinases, and inflammatory cytokines, are known to play a detrimental role in OA. However, these factors do not initiate OA, but are mediators or consequences of the disease, while many other factors causing the etiology of OA are still unknown. Here, it is revealed that microenvironmental osmolarity can induce and reverse osteoarthritis‐related behavior of chondrocytes via altered intracellular molecular crowding, which represents a previously unknown mechanism underlying OA pathophysiology. Decreased intracellular crowding is associated with increased sensitivity to proinflammatory triggers and decreased responsiveness to anabolic stimuli. OA‐induced lowered intracellular molecular crowding could be renormalized via exposure to higher extracellular osmolarity such as those found in healthy joints, which reverse OA chondrocyte's sensitivity to catabolic stimuli as well as its glycolytic metabolism.
Mechanotransduction is widely used to guide cell fate in hydrogels. Traditionally, hydrogels contain adhesive ligands that dynamically bond with cells to stimulate biochemical signaling axes such as YAP‐TAZ. However, the molecular toolbox to achieve mechanotransduction remains virtually limited to non‐covalent bonds, which limits the ability to program engineered living matter. Here, it is demonstrated that on‐cell chemistry can be leveraged to covalently tether biomaterials directly onto cells, that reveal mechanotransduction via intracellular biophysical programming. Specifically, droplet microfluidics is used to produce single‐cell microgels in which individual stem cells are covalently tethered to either soft or stiff hydrogels via on‐cell oxidative phenolic coupling. Investigation of mechanotransduction effects at single‐cell resolution reveals altered intracellular molecular crowding, calcium signaling, and chromatin organization by regulating cytoplasmic and nuclear volume in a stiffness‐dependent yet YAP/TAZ‐independent manner. Notably, the addition of conventional dynamic adhesive ligands such as RGDs decreases the chondrogenic commitment of stem cells indicating that covalent cell‐material tethering is both efficient and sufficient for programming cell fate. Hence, encoding biomaterials onto cells using covalent on‐cell chemistry to attain mechanotransduction expands the ability to guide cellular behavior, which can accelerate the development of in vitro drug‐screening models, biofabrication of lab‐grown meat, and engineered tissues.
Extracellular matrix (ECM) guides cell behavior and tissue fate. Cell populations are notoriously heterogeneous leading to large variations in cell behavior at the single‐cell level. Although insights into population heterogeneity are valuable for fundamental biology, regenerative medicine, and drug testing, current ECM analysis techniques only provide either averaged population‐level data or single‐cell data from a limited number of cells. Here, extracellular protein identification cytometry (EPIC) is presented as a novel platform technology that enables high‐throughput measurements of local nascent protein deposition at single‐cell level. Specifically, human primary chondrocytes are microfluidically encapsulated in enzymatically crosslinked microgels of 16 picoliter at kHz rates, forming large libraries of discrete 3D single‐cell microniches in which ECM can be deposited. ECM proteins are labeled using fluorescence immunostaining to allow for nondestructive analysis via flow cytometry. This approach reveals population heterogeneity in matrix deposition at unprecedented throughput, allowing for the identification and fluorescent activated cell sorting‐mediated isolation of cellular subpopulations. Additionally, it is demonstrated that inclusion of a second cell into microgels allows for studying the effect of cell‐cell contact on matrix deposition. In summary, EPIC enables high‐throughput single‐cell analysis of nascent proteins in 3D microenvironments, which is anticipated to advance fundamental knowledge and tissue engineering applications.
Three-dimensional (3D) cell culture systems exhibit more native-like cell behaviour compared to conventional two-dimensional (2D) cell culture systems. However, it remains largely unknown how dimensionality alters cell behaviour. Here, we identify intracellular crowding as a key biophysical parameter altered by cell culture dimensionality, which directs cell fate over a mechano-metabolic axis. Specifically, culture dimensionality controlled intracellular crowding by altering cell volume, which was confirmed across multiple cell types and cell culture platforms. Using chondrogenesis as a model system, we demonstrated that dimensionality-induced intracellular changes lead to improved chondrogenic stem cell differentiation in microtissue culture via a FOXO1 signalling axis. Our findings highlight intracellular crowding as an important parameter of cell culture systems, and present a novel strategy for engineering biomimetic cell culture systems, which has implications for a multitude of applications including disease modelling, in vitro drug screening models, developmental biology, and cell-based therapies.